Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$42.4K Sell
117
-43
-27% -$14.7K 0.03% 117
2026
Q1
$56.3K Hold
160
0.04% 86
2025
Q4
$52.4K Hold
160
0.04% 91
2025
Q3
$45.1K Hold
160
0.03% 89
2025
Q2
$44.7K Sell
160
-60
-27% -$17K 0.04% 102
2025
Q1
$68.5K Hold
220
0.06% 58
2024
Q4
$57.3K Hold
220
0.05% 62
2024
Q3
$70.9K Hold
220
0.06% 57
2024
Q2
$67.3K Hold
220
0.06% 52
2024
Q1
$60.2K Hold
220
0.06% 58
2023
Q4
$59.3K Sell
220
-60
-21% -$16.3K 0.06% 56
2023
Q3
$75.3K Hold
280
0.08% 53
2023
Q2
$62.2K Hold
280
0.06% 62
2023
Q1
$64.9K Hold
280
0.07% 62
2022
Q4
$80K Hold
280
0.08% 60
2022
Q3
$63K Hold
280
0.07% 64
2022
Q2
$68K Sell
280
-70
-20% -$17.2K 0.08% 64
2022
Q1
$85K Hold
350
0.09% 61
2021
Q4
$79K Hold
350
0.08% 72
2021
Q3
$74K Sell
350
-20
-5% -$4.6K 0.08% 69
2021
Q2
$90K Buy
370
+20
+6% +$4.92K 0.1% 67
2021
Q1
$87K Buy
+350
New +$83.5K 0.11% 64

Other funds holding AMGN

Hoese & Co's AMGN Position: Q2 2026 in Review

Hoese & Co reduced its Amgen (AMGN) stake by 27% in Q2 2026, selling an estimated $14.7K and leaving 117 shares worth $42.4K. The position accounts for 0.03% of the portfolio, ranked #117.

Hoese & Co first reported a position in AMGN in Q1 2021 and has held it in 22 quarters since. The position peaked at $90K in Q2 2021. 1,055 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Hoese & Co held 117 shares of Amgen worth $42.4K as of Q2 2026.
  • Hoese & Co sold 43 Amgen shares in Q2 2026, an estimated $14.7K.
  • Amgen made up 0.03% of Hoese & Co's portfolio in Q2 2026, its #117 holding.
  • Hoese & Co first reported a position in Amgen in Q1 2021 and has held it in 22 quarters since.
  • Hoese & Co's Amgen position peaked at $90K in Q2 2021.
  • 1,055 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Hoese & Co's 13F filing for Q2 2026, filed 14 Jul 2026.